European Respiratory Society course participants to study with latest technology through Esaote partnership

Participants in several educational courses and workshops run by the European Respiratory Society (ERS) will have access to the latest advances in thoracic and pulmonary imaging technology through the society’s partnership with Esaote.

The three-year partnership will see Esaote supply its thoracic ultrasound devices for the thoracic ultrasound (TUS) training programme, including regional courses due to take place in the UK, Denmark and the Netherlands.

Esaote devices are also used as part of TUS activities at the ERS International Congress. During the Milan congress, these included the TUS training programme OSCE examination and use in a skills workshop. This will continue at the 2024 congress in Vienna.

ERS education council chair Professor Hilary Pinnock said: “Access to the latest technology as part of education is crucial, particularly for early career respiratory medical professionals. We’re already seeing direct benefits of this partnership in the success of our TUS training programme, among other courses, and look forward to seeing this partnership develop.”

Esaote offers transducers and automatic tools that help accelerate the early detection and treatment of respiratory complications, such as mechanical ventilation. Advanced features may support the characterisation of some lesions, such as CnTI Clear, which enables the use of contrast agents.

“The new generation of XCrystal transducers allows the acquisition of detailed images with high temporal and spatial resolution without any compromise in the deep areas, which is crucial in lung ultrasound examinations, thus enhancing diagnostic confidence in any clinical setting,” said Esaote global product manager Martina Cereseto.

Picture: ERS course will use Esaote’s TUS devices.

Published on page 10 of the January 2024 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more